{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:32:10Z","timestamp":1792085530988,"version":"4.4.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015769","name":"Dexcom","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001279","name":"Great Ormond Street Hospital Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Continuous glucose monitoring (CGM) is the standard of care for glucose monitoring in children with diabetes, however there are limited data reporting their use in hyperinsulinaemic hypoglycaemia (HH). Here, we evaluate CGM accuracy and its impact on quality of life in children with HH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Real-time CGM (Dexcom G5 and G6) was used in children with HH aged 0-16years. Data from self-monitoring capillary blood glucose (CBG) and CGM were collected over a period of up to 28days and analysed. Quality of life was assessed by the PedsQL4.0 general module and PedsQL2.0 family impact module, completed by children and their parents\/carers before and after CGM insertion. Analysis of accuracy metrics included mean absolute relative difference (MARD) and proportion of CGM values within 15, 20, and 30% or 15, 20, and 30 mg\/dL of reference glucose values &amp;gt;100 mg\/dL or \u2264100 mg\/dL, respectively (% 15\/15, % 20\/20, % 30\/30). Clinical reliability was assessed with Clarke error grid (CEG) analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Prospective longitudinal study with data analysed from 40 children. The overall MARD between reference glucose and paired CGM values (n=4,928) was 13.0% (Dexcom G5 12.8%, Dexcom G6 13.1%). The proportion of readings meeting %15\/15 and %20\/20 were 77.3% and 86.4%, respectively, with CEG analysis demonstrating 97.4% of all values in zones A and B. Within the hypoglycaemia range (&amp;lt;70 mg\/dL), the median ARD was 11.4% with a sensitivity and specificity of 64.2% and 91.3%, respectively. Overall PedsQL child report at baseline and endpoint were 57.6 (50.5 \u2013 75.8) and 87.0 (82.9 \u2013 91.2), and for parents were 60.3 (44.8 \u2013 66.0) and 85.3 (83.7 \u2013 91.3), respectively (both p&amp;lt;0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Use of CGM for children with HH is feasible, with clinically acceptable accuracy, particularly in the hypoglycaemic range. Quality of life measures demonstrate significant improvement after CGM use. These data are important to explore use of CGM in disease indications, including neonatal and paediatric diabetes, cystic fibrosis and glycogen storage disorders.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1265076","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T10:46:26Z","timestamp":1695811586000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Accuracy and impact on quality of life of real-time continuous glucose monitoring in children with hyperinsulinaemic hypoglycaemia"],"prefix":"10.3389","volume":"14","author":[{"given":"Madhini","family":"Sivasubramanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parizad","family":"Avari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Doodson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratik","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/ADC.2006.115543","article-title":"Hyperinsulinaemic hypoglycaemia: biochemical basis and the importance of maintaining normoglycaemia during management","volume":"92","author":"Hussain","year":"2007","journal-title":"Arch Dis Child."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2017.00156","article-title":"Both low blood glucose and insufficient treatment confer risk of neurodevelopmental impairment in congenital hyperinsulinism: A multinational cohort study","volume":"8","author":"Helleskov","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1542\/PEDS.2007-2822","article-title":"Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia","volume":"122","author":"Burns","year":"2008","journal-title":"Pediatrics"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/01.OPX.0000153266.50875.53","article-title":"Relationship between visual-motor integration and spatial organization of written language and math","volume":"82","author":"Barnhardt","year":"2005","journal-title":"Optom Vis Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1159\/000492859","article-title":"Neonatal glycaemia and neurodevelopmental outcomes: A systematic review and meta-analysis","volume":"115","author":"Shah","year":"2019","journal-title":"Neonatology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000481774","article-title":"Formal neurocognitive testing in 60 patients with congenital hyperinsulinism","volume":"89","author":"Ludwig","year":"2018","journal-title":"Horm Res Paediatr"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(16)30323-0","article-title":"Hyperinsulinaemic hypoglycaemia in children and adults","volume":"5","author":"Shah","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13942","article-title":"Is it possible to constantly and accurately monitor blood sugar levels, in people with Type 1 diabetes, with a discrete device (non-invasive or invasive)","volume":"37","author":"Avari","year":"2020","journal-title":"Diabetes Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2708-9","article-title":"The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial","volume":"55","author":"Battelino","year":"2012","journal-title":"Diabetologia"},{"key":"B10","volume-title":"Type 1 diabetes in adults: diagnosis and management, Guidance and guidelines (NG17)","year":"2015"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/FPED.2022.901338","article-title":"Congenital hyperinsulinism in clinical practice: From biochemical pathophysiology to new monitoring techniques","volume":"10","author":"Martino","year":"2022","journal-title":"Front Pediatr"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/CLINEM\/DGAB601","article-title":"Continuous glucose monitoring in the management of neonates with persistent hypoglycemia and congenital hyperinsulinism","volume":"107","author":"Win","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1159\/000506230","article-title":"Continuous glucose monitoring systems: Are they useful for evaluating glycemic control in children with hyperinsulinism","volume":"92","author":"Rayannavar","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2022.1016072","article-title":"The hypoglycaemia error grid: A UK-wide consensus on CGM accuracy assessment in hyperinsulinism","volume":"13","author":"Worth","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/S13633-018-0057-2","article-title":"Continuous Flash Glucose Monitoring in children with Congenital Hyperinsulinism; first report on accuracy and patient experience","volume":"2018","author":"Alsaffar","year":"2018","journal-title":"Int J Pediatr Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/BMJDRC-2022-002849","article-title":"Insight into hypoglycemia frequency in congenital hyperinsulinism: evaluation of a large UK CGM dataset","volume":"10","author":"Worth","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B17","unstructured":""},{"key":"B18","doi-asserted-by":"publisher","first-page":"S","DOI":"10.1089\/dia.2008.0138","article-title":"Statistical tools to analyze continuous glucose monitor data","volume":"11","author":"Clarke","year":"2009","journal-title":"Diabetes Technol Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2019.0416","article-title":"Updated software for automated assessment of glucose variability and quality of glycemic control in diabetes","volume":"22","author":"Moscard\u00f3","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2337\/DIACARE.10.5.622","article-title":"Evaluating clinical accuracy of systems for self-monitoring of blood glucose","volume":"10","author":"Clarke","year":"1987","journal-title":"Diabetes Care"},{"key":"B21","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2337\/DC10-1989","article-title":"Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes","volume":"34","author":"Battelino","year":"2011","journal-title":"Diabetes Care"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.5114\/PEDM.2018.80994","article-title":"Hypoglycaemia unawareness in patients with type 1 diabetes","volume":"2018","author":"Szadkowska","year":"2018","journal-title":"Pediatr Endocrinol Diabetes Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)30297-6","article-title":"Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial","volume":"391","author":"Heinemann","year":"2018","journal-title":"Lancet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13561","article-title":"A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia","volume":"35","author":"Reddy","year":"2018","journal-title":"Diabetes Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2337\/DC20-1531","article-title":"Sustained impact of real-time continuous glucose monitoring in adults with type 1 diabetes on insulin pump therapy: Results after the 24-month RESCUE study","volume":"43","author":"Charleer","year":"2020","journal-title":"Diabetes Care"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/JENDSO\/BVAC060","article-title":"Continuous glucose monitoring profiles in healthy, nondiabetic young children","volume":"6","author":"Dubose","year":"2022","journal-title":"J Endocr Soc"},{"key":"B27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/S13023-022-02214-Y","article-title":"Congenital hyperinsulinism in infancy and childhood: Challenges, unmet needs and the perspective of patients and families","volume":"17","author":"Banerjee","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2022.894559","article-title":"Families\u2019 Experiences of continuous glucose monitoring in the management of congenital hyperinsulinism: A thematic analysis","volume":"13","author":"Auckburally","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/ARCHDISCHILD-2022-323872","article-title":"Case for funding of continuous glucose monitoring systems for patients with recurrent hypoglycaemia","volume":"6","author":"Ng","year":"2022","journal-title":"Arch Dis Child"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1177\/20552076221129712","article-title":"HYPO-CHEAT\u2019s aggregated weekly visualisations of risk reduce real world hypoglycaemia","volume":"8","author":"Worth","year":"2022","journal-title":"Digit Heal"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1265076\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T10:46:29Z","timestamp":1695811589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1265076\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,26]]},"references-count":30,"alternative-id":["10.3389\/fendo.2023.1265076"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1265076","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,26]]},"article-number":"1265076"}}